Ocular Therapeutix OCUL Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Ocular Therapeutix’s reported figures.
Based on trailing twelve months.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's free cash flow yield?
- Ocular Therapeutix (OCUL) reported free cash flow yield of -13.1% in Q1 2026.
- How has Ocular Therapeutix's free cash flow yield changed year-over-year?
- Ocular Therapeutix's free cash flow yield decreased by 2.6% year-over-year, from -12.7% to -13.1%.
- What is the long-term trend for Ocular Therapeutix's free cash flow yield?
- Over 5 years (2020 to 2025), Ocular Therapeutix's free cash flow yield has grown at a 19.6% compound annual growth rate (CAGR), from -3.4% to -8.4%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.